E-LIB Suche - Ergebnisse für: Huntington, Jennifer A.

1

Outcomes in participants with ventilated nosocomial pneumon..:

Martin-Loeches, Ignacio ; Shorr, Andrew F. ; Wunderink, Richard G....
Annals of Intensive Care. 13 (2023) 1 - p. , 2023

2

Safety and Efficacy of Ceftolozane/Tazobactam Plus Metronid..:

Jackson, Carl-Christian A. ; Newland, Jason ; Dementieva, Nataliia...
Pediatric Infectious Disease Journal. 42 (2023) 7 - p. 557-563 , 2023

Link: https://doi.org/10.1097/..

3

Subgroup analysis of phase 2 study of ceftolozane/tazobacta..:

Roilides, Emmanuel ; Bradley, John S. ; Lonchar, Julia...
Microbiology Spectrum. 11 (2023) 5 - p. , 2023

Link: https://doi.org/10.1128/..

4

Safety and Efficacy of Ceftolozane/Tazobactam Versus Merope..:

Roilides, Emmanuel ; Ashouri, Negar ; Bradley, John S....
Pediatric Infectious Disease Journal. 42 (2023) 4 - p. 292-298 , 2023

Link: https://doi.org/10.1097/..

5

Outcomes in participants with failure of initial antibacter..:

Kollef, Marin H. ; Timsit, Jean-François ; Martin-Loeches, Ignacio...
Critical Care. 26 (2022) 1 - p. , 2022

Link: https://doi.org/10.1186/..

6

A phase III, multicenter, double-blind, randomized clinical..:

Sun, Yihong ; Fan, Jia ; Chen, Gang...
International Journal of Infectious Diseases. 123 (2022) - p. 157-165 , 2022

Link: https://doi.org/10.1016/..

7

Clinical and microbiological outcomes, by causative pathoge..:

Martin-Loeches, Ignacio ; Timsit, Jean-François ; Kollef, Marin H....
Journal of Antimicrobial Chemotherapy. 77 (2022) 4 - p. 1166-1177 , 2022

Link: https://doi.org/10.1093/..

8

Ceftolozane/tazobactam for hospital-acquired/ventilator-ass..:

Paterson, David L ; Bassetti, Matteo ; Motyl, Mary...
Journal of Antimicrobial Chemotherapy. 77 (2022) 9 - p. 2522-2531 , 2022

Link: https://doi.org/10.1093/..

9

1154. Safety and Efficacy of Ceftolozane/Tazobactam Plus Me..:

Jackson, Carl-Christian A ; Newland, Jason ; Dementieva, Natalia...
Open Forum Infectious Diseases. 8 (2021) Supplement_1 - p. S668-S669 , 2021

Link: https://doi.org/10.1093/..

10

1143. Safety and Efficacy of Ceftolozane/Tazobactam Versus ..:

Roilides, Emmanuel ; Ashouri, Negar ; Bradley, John S...
Open Forum Infectious Diseases. 8 (2021) Supplement_1 - p. S663-S664 , 2021

Link: https://doi.org/10.1093/..

11

Ceftolozane/tazobactam versus meropenem in patients with ve..:

Timsit, Jean-François ; Huntington, Jennifer A. ; Wunderink, Richard G....
Critical Care. 25 (2021) 1 - p. , 2021

Link: https://doi.org/10.1186/..

12

Evaluating the emergence of nonsusceptibility among Pseudom..:

Johnson, Matthew G. ; Bruno, Christopher ; Castanheira, Mariana...
International Journal of Antimicrobial Agents. 57 (2021) 3 - p. 106278 , 2021

Link: https://doi.org/10.1016/..

13

110. A Phase 3, Multicenter, Double-blind, Randomized Clini..:

Sun, Yihong ; Fan, Jia ; Chen, Gang...
Open Forum Infectious Diseases. 8 (2021) Supplement_1 - p. S67-S68 , 2021

Link: https://doi.org/10.1093/..

14

Ceftolozane/tazobactam probability of target attainment and..:

Shorr, Andrew F. ; Bruno, Christopher J. ; Zhang, Zufei...
Critical Care. 25 (2021) 1 - p. , 2021

Link: https://doi.org/10.1186/..

15

Ceftolozane–tazobactam versus meropenem for treatment of no..:

Kollef, Marin H ; Nováček, Martin ; Kivistik, Ülo...
The Lancet Infectious Diseases. 19 (2019) 12 - p. 1299-1311 , 2019

Link: https://doi.org/10.1016/..